Historical Archive

Exports: Intesa Sanpaolo, a pharmaceutical company driven by Lazio

January 17, 2013 – 11:52 am

(ASCA) - Rome, Jan. 17 - It is the pharmaceutical hub that drives the Lazio economy in the third quarter of 2012 with growth of 19.4%. The Lazio pharmaceutical sector continues to grow at a faster pace than the national sectoral figure (+7.1%).

The most recent dynamics of the sector highlight significant criticalities on the internal market, conditioned by increasingly stringent policies to contain public expenditure, which are contrasted, however, by the brilliant results obtained on foreign markets (especially France, Germany, Belgium, the Netherlands, the United Kingdom and the United States). Roman ICT also closed the third quarter positively (+6%) showing better dynamics than the average of the monitored ICT poles (-6.4%). In this case, it was mainly the United Kingdom that drove exports, while exports to Germany recorded a sharp slowdown (-48.3%). Despite the positive data on foreign markets, the performance of ICT companies is deeply affected by the blockage of infrastructure investments, as can also be seen from the critical data on the labor market.

The third quarter of 2012 proved to be a difficult quarter for the ceramic district of Civita Castellana which, specialized in sanitary ceramics, is suffering from the recovery difficulties of the real estate sector of the main commercial partners Spain and the United Kingdom.

In the third quarter, exports recorded a (trend) contraction of 13.9%.

An overall positive picture of international trade contrasts with a critical scenario on the employment front, as emerges from the data on the use of social safety nets in the first eleven months of 2012. In the Lazio technology hubs, the hours of layoffs in the first eleven months of 2012 increased by 27.1% in contrast to the national trend (down by 5.3%).

 

 

 

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco